VVUS Cash Flow Statement

Click line-items for a historical chart and %
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss from continuing operations
Adjustments to reconcile net loss to net cash used for operating activities from continuing operations:
Depreciation
Share-based compensation expense 6.06M
Changes in assets and liabilities:
Inventories -7.07M
Prepaid expenses and other assets -5.17M
Accounts payable -6.88M
Accrued research and clinical expenses
Accrued employee compensation and benefits
Accrued and other liabilities 879K
Net cash used for operating activities from continuing operations -61.92M
Net cash (used for) provided by operating activities from discontinued operations -204K
Net cash used for operating activities -62.12M
CASH FLOWS FROM INVESTING ACTIVITIES:
Property and equipment purchases -929K
Investment purchases
Proceeds from sale/maturity of securities
Net cash provided by investing activities from continuing operations
Net cash used for investing activities from discontinued operations
Net cash provided by investing activities 94.12M
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from exercise of common stock options 4K
Sale of common stock through employee stock purchase plan
Net cash provided by financing activities from continuing operations
Net cash used for financing activities from discontinued operations
Net cash provided by financing activities 4K
NET DECREASE IN CASH AND CASH EQUIVALENTS 32M
CASH AND CASH EQUIVALENTS:
Beginning of period 58.61M
End of period 90.61M

Entities mentioned with VVUS

View All Entities